{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T07:01:13Z","timestamp":1777705273614,"version":"3.51.4"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,9,20]],"date-time":"2020-09-20T00:00:00Z","timestamp":1600560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,20]],"date-time":"2020-09-20T00:00:00Z","timestamp":1600560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Peking University Health Science centre","award":["69003Y0052"],"award-info":[{"award-number":["69003Y0052"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s11096-020-01037-w","type":"journal-article","created":{"date-parts":[[2020,9,20]],"date-time":"2020-09-20T07:02:42Z","timestamp":1600585362000},"page":"1364-1368","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Dipeptidyl peptidase-4 inhibitors and risk of venous thromboembolism: data mining of FDA adverse event reporting system"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4358-132X","authenticated-orcid":false,"given":"Wenchao","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shusen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingkai","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sydney","family":"Thai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dandan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huilin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiansheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lulu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,20]]},"reference":[{"issue":"4","key":"1037_CR1","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s40264-017-0618-y","volume":"41","author":"M Arnaud","year":"2018","unstructured":"Arnaud M, B\u00e9gaud B, Thiessard F, Jarrion Q, Bezin J, Pariente A, et al. An automated system combining safety signal detection and prioritization from healthcare databases: a pilot study. Drug Saf. 2018;41(4):377\u201387.","journal-title":"Drug Saf"},{"issue":"1","key":"1037_CR2","doi-asserted-by":"publisher","first-page":"e003277","DOI":"10.1161\/JAHA.112.003277","volume":"2","author":"M Ayaori","year":"2013","unstructured":"Ayaori M, Iwakami N, Uto-Kondo H, Sato H, Sasaki M, Komatsu T, et al. Dipeptidyl peptidase-4 inhibitors attenuate endothelial function as evaluated by flow-mediated vasodilatation in type 2 diabetic patients. J Am Heart Assoc. 2013;2(1):e003277.","journal-title":"J Am Heart Assoc."},{"issue":"10063","key":"1037_CR3","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1016\/S0140-6736(16)30514-1","volume":"388","author":"M Di Nisio","year":"2016","unstructured":"Di Nisio M, van Es N, B\u00fcller HR. Deep vein thrombosis and pulmonary embolism. Lancet. 2016;388(10063):3060\u201373.","journal-title":"Lancet"},{"issue":"3","key":"1037_CR4","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00125-018-4801-1","volume":"62","author":"P Home","year":"2019","unstructured":"Home P. Cardiovascular outcome trials of glucose-lowering medications: an update. Diabetologia. 2019;62(3):357\u201369.","journal-title":"Diabetologia"},{"issue":"Suppl 2","key":"1037_CR5","doi-asserted-by":"publisher","first-page":"S196","DOI":"10.2337\/dcS15-3024","volume":"39","author":"E Mannucci","year":"2016","unstructured":"Mannucci E, Mosenzon O, Avogaro A. Analyses of results from cardiovascular safety trials with DPP-4 inhibitors: cardiovascular outcomes, predefined safety outcomes, and pooled analysis and meta-analysis. Diabetes Care. 2016;39(Suppl 2):S196\u2013204.","journal-title":"Diabetes Care"},{"issue":"7","key":"1037_CR6","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/nbt.3623","volume":"34","author":"M Sarangdhar","year":"2016","unstructured":"Sarangdhar M, Tabar S, Schmidt C, Kushwaha A, Shah K, Dahlquist JE, et al. Data mining differential clinical outcomes associated with drug regimens using adverse event reporting data. Nat Biotechnol. 2016;34(7):697\u2013700.","journal-title":"Nat Biotechnol"},{"issue":"6","key":"1037_CR7","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/pds.677","volume":"10","author":"SJ Evans","year":"2001","unstructured":"Evans SJ, Waller PC, Davis S. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf. 2001;10(6):483\u20136.","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"8","key":"1037_CR8","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1002\/dmrr.2804","volume":"32","author":"T Wang","year":"2016","unstructured":"Wang T, Wang F, Zhou J, Tang H, Giovenale S. Adverse effects of incretin-based therapies on major cardiovascular and arrhythmia events: meta-analysis of randomized trials. Diabetes Metab Res Rev. 2016;32(8):843\u201357.","journal-title":"Diabetes Metab Res Rev"},{"issue":"2","key":"1037_CR9","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1001\/jamacardio.2018.4537","volume":"4","author":"J Gregson","year":"2019","unstructured":"Gregson J, Kaptoge S, Bolton T, Pennells L, Willeit P, Burgess S, et al. Cardiovascular risk factors associated with venous thromboembolism. Version 2. JAMA Cardiol. 2019;4(2):163\u201373.","journal-title":"JAMA Cardiol."},{"issue":"3","key":"1037_CR10","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jacc.2011.07.053","volume":"59","author":"J Matsubara","year":"2012","unstructured":"Matsubara J, Sugiyama S, Sugamura K, Nakamura T, Fujiwara Y, Akiyama E, et al. A dipeptidyl peptidase-4 inhibitor, des-fluoro-sitagliptin, improves endothelial function and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice. J Am Coll Cardiol. 2012;59(3):265\u201376.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"1037_CR11","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.2337\/dc10-2421","volume":"34","author":"PC Van Poppel","year":"2011","unstructured":"Van Poppel PC, Netea MG, Smits P, Tack CJ. Vildagliptin improves endothelium-dependent vasodilatation in type 2 diabetes. Diabetes Care. 2011;34(9):2072\u20137.","journal-title":"Diabetes Care"},{"issue":"12","key":"1037_CR12","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.2337\/dc18-0050","volume":"41","author":"E Chow","year":"2018","unstructured":"Chow E, Iqbal A, Walkinshaw E, Phoenix F, Macdonald IA, Storey RF, et al. Prolonged prothrombotic effects of antecedent hypoglycemia in individuals with type 2 diabetes. Diabetes Care. 2018;41(12):2625\u201333.","journal-title":"Diabetes Care"},{"key":"1037_CR13","unstructured":"Questions and Answers on FDA\u2019s Adverse Event Reporting System (FAERS). https:\/\/www.fda.gov\/drugs\/surveillance\/fda-adverse-event-reporting-system-faers. Accessed 29 Sept 2019."},{"issue":"6","key":"1037_CR14","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s11739-010-0413-6","volume":"5","author":"V De Stefano","year":"2010","unstructured":"De Stefano V, Martinelli I. Splanchnic vein thrombosis: clinical presentation, risk factors and treatment. Intern Emerg Med. 2010;5(6):487\u201394.","journal-title":"Intern Emerg Med"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-020-01037-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-020-01037-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-020-01037-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,19]],"date-time":"2021-09-19T23:58:27Z","timestamp":1632095907000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-020-01037-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,20]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["1037"],"URL":"https:\/\/doi.org\/10.1007\/s11096-020-01037-w","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,20]]},"assertion":[{"value":"11 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Authors declare that there is no conflict of interest associated with this manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study requires no ethics approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}